Cargando…
Pulmonary lipid modulation: A possible therapeutic target for SARS-CoV-2 infection
Autores principales: | Mandato, Claudia, Vajro, Pietro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874912/ https://www.ncbi.nlm.nih.gov/pubmed/33621842 http://dx.doi.org/10.1016/j.mehy.2021.110529 |
Ejemplares similares
-
More on Current Evidences on Probiotics as a Novel Treatment for Non-Alcoholic Fatty Liver Disease
por: Vajro, Pietro, et al.
Publicado: (2013) -
Setting the criteria for SARS-CoV-2 reinfection – six possible cases
por: Tomassini, Sara, et al.
Publicado: (2021) -
SARS-CoV-2 infection: possible underdiagnosis of cerebral venous sinus thrombosis()
por: Almarcha-Menargues, M.L., et al.
Publicado: (2021) -
Pulmonary embolism rate in patients infected with SARS-CoV-2
por: Capaccione, Kathleen M., et al.
Publicado: (2020) -
Prediction of pulmonary embolism in patients with SARS-CoV-2 infection
por: Franco-Moreno, Anabel, et al.
Publicado: (2023)